Myriad Pharmaceuticals, Inc. Elects Timothy R. Franson, M.D. to Its Board of Directors
SALT LAKE CITY, Sept. 15, 2009 (GLOBE NEWSWIRE) -- Myriad Pharmaceuticals, Inc. (Nasdaq:MYRX) announced today that it has elected Timothy R. Franson, M.D. to its Board of Directors. Dr. Franson's term is effective as of September 10, 2009. With the addition of Dr. Franson, Myriad Pharmaceuticals, Inc. now has five independent Directors elected to its Board.